Sector 10, Inc. (SECI)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0050

0.0000

(0.00%)

At close: 12:48PM EST

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0050
Open	0.0050
Bid	0.0005 x 5000
Ask	0.0200 x 5000
Day's Range	0.0050 - 0.0050
52 Week Range	0.0021 - 0.0305
Volume	2
Avg. Volume	0

Market Cap	1,529
Beta (5Y Monthly)	-3,225.68
PE Ratio (TTM)	0.05
EPS (TTM)	0.1100
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SECI

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

SECTOR 10 INC
Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
Rating
Fair Value
Economic Moat
10 months agoMorningstar